Psoriasis and the Framingham risk score in a Danish hospital cohort

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Psoriasis and the Framingham risk score in a Danish hospital cohort. / Gyldenløve, Mette; Jensen, Peter; Linneberg, Allan; Thyssen, Jacob P; Zachariae, Claus; Hansen, Peter R; Skov, Lone.

In: International Journal of Dermatology, Vol. 53, No. 9, 09.2014, p. 1086-1090.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Gyldenløve, M, Jensen, P, Linneberg, A, Thyssen, JP, Zachariae, C, Hansen, PR & Skov, L 2014, 'Psoriasis and the Framingham risk score in a Danish hospital cohort', International Journal of Dermatology, vol. 53, no. 9, pp. 1086-1090. https://doi.org/10.1111/ijd.12196

APA

Gyldenløve, M., Jensen, P., Linneberg, A., Thyssen, J. P., Zachariae, C., Hansen, P. R., & Skov, L. (2014). Psoriasis and the Framingham risk score in a Danish hospital cohort. International Journal of Dermatology, 53(9), 1086-1090. https://doi.org/10.1111/ijd.12196

Vancouver

Gyldenløve M, Jensen P, Linneberg A, Thyssen JP, Zachariae C, Hansen PR et al. Psoriasis and the Framingham risk score in a Danish hospital cohort. International Journal of Dermatology. 2014 Sep;53(9):1086-1090. https://doi.org/10.1111/ijd.12196

Author

Gyldenløve, Mette ; Jensen, Peter ; Linneberg, Allan ; Thyssen, Jacob P ; Zachariae, Claus ; Hansen, Peter R ; Skov, Lone. / Psoriasis and the Framingham risk score in a Danish hospital cohort. In: International Journal of Dermatology. 2014 ; Vol. 53, No. 9. pp. 1086-1090.

Bibtex

@article{e12d55cef2c241d4b1b5348b7474ef5f,
title = "Psoriasis and the Framingham risk score in a Danish hospital cohort",
abstract = "BACKGROUND: Psoriasis is a chronic inflammatory skin disease, which is associated with an increased risk of cardiovascular morbidity and mortality. Our aim was to compare the Framingham risk score, a method to estimate coronary heart disease and prevalences of cardiovascular risk factors in patients with psoriasis and the general population.METHODS: We retrospectively studied a hospital cohort and used a cross-sectional random sample from the general population as controls.RESULTS: A total of 185 patients with psoriasis aged 10-86 years were referred to our department during 2009-2011. Median psoriasis area and severity index score was 5.8 (range 0.0-39.8), and 10{\%} of the patients received systemic antipsoriatic treatment. Body mass index (26.2 vs. 25.2 kg/m(2) , P = 0.005), waist circumference (96.0 vs. 88.0 cm, P < 0.001), and prevalence of hypercholesterolemia (15.1 vs. 14.5, P = 0.009) were significantly higher in patients with psoriasis. We found no significant differences in Framingham risk scores between the groups.CONCLUSIONS: Patients from the hospital cohort had a higher prevalence of certain cardiovascular risk factors compared to individuals without psoriasis from the general population. However, the Framingham risk score did not demonstrate an excess risk of coronary heart disease in patients with psoriasis compared to controls.",
author = "Mette Gyldenl{\o}ve and Peter Jensen and Allan Linneberg and Thyssen, {Jacob P} and Claus Zachariae and Hansen, {Peter R} and Lone Skov",
note = "{\circledC} 2013 The International Society of Dermatology.",
year = "2014",
month = "9",
doi = "10.1111/ijd.12196",
language = "English",
volume = "53",
pages = "1086--1090",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "9",

}

RIS

TY - JOUR

T1 - Psoriasis and the Framingham risk score in a Danish hospital cohort

AU - Gyldenløve, Mette

AU - Jensen, Peter

AU - Linneberg, Allan

AU - Thyssen, Jacob P

AU - Zachariae, Claus

AU - Hansen, Peter R

AU - Skov, Lone

N1 - © 2013 The International Society of Dermatology.

PY - 2014/9

Y1 - 2014/9

N2 - BACKGROUND: Psoriasis is a chronic inflammatory skin disease, which is associated with an increased risk of cardiovascular morbidity and mortality. Our aim was to compare the Framingham risk score, a method to estimate coronary heart disease and prevalences of cardiovascular risk factors in patients with psoriasis and the general population.METHODS: We retrospectively studied a hospital cohort and used a cross-sectional random sample from the general population as controls.RESULTS: A total of 185 patients with psoriasis aged 10-86 years were referred to our department during 2009-2011. Median psoriasis area and severity index score was 5.8 (range 0.0-39.8), and 10% of the patients received systemic antipsoriatic treatment. Body mass index (26.2 vs. 25.2 kg/m(2) , P = 0.005), waist circumference (96.0 vs. 88.0 cm, P < 0.001), and prevalence of hypercholesterolemia (15.1 vs. 14.5, P = 0.009) were significantly higher in patients with psoriasis. We found no significant differences in Framingham risk scores between the groups.CONCLUSIONS: Patients from the hospital cohort had a higher prevalence of certain cardiovascular risk factors compared to individuals without psoriasis from the general population. However, the Framingham risk score did not demonstrate an excess risk of coronary heart disease in patients with psoriasis compared to controls.

AB - BACKGROUND: Psoriasis is a chronic inflammatory skin disease, which is associated with an increased risk of cardiovascular morbidity and mortality. Our aim was to compare the Framingham risk score, a method to estimate coronary heart disease and prevalences of cardiovascular risk factors in patients with psoriasis and the general population.METHODS: We retrospectively studied a hospital cohort and used a cross-sectional random sample from the general population as controls.RESULTS: A total of 185 patients with psoriasis aged 10-86 years were referred to our department during 2009-2011. Median psoriasis area and severity index score was 5.8 (range 0.0-39.8), and 10% of the patients received systemic antipsoriatic treatment. Body mass index (26.2 vs. 25.2 kg/m(2) , P = 0.005), waist circumference (96.0 vs. 88.0 cm, P < 0.001), and prevalence of hypercholesterolemia (15.1 vs. 14.5, P = 0.009) were significantly higher in patients with psoriasis. We found no significant differences in Framingham risk scores between the groups.CONCLUSIONS: Patients from the hospital cohort had a higher prevalence of certain cardiovascular risk factors compared to individuals without psoriasis from the general population. However, the Framingham risk score did not demonstrate an excess risk of coronary heart disease in patients with psoriasis compared to controls.

U2 - 10.1111/ijd.12196

DO - 10.1111/ijd.12196

M3 - Journal article

C2 - 23879194

VL - 53

SP - 1086

EP - 1090

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 9

ER -

ID: 138500952